Table 2.
Experimental design of injected mouse cohorts.
| Mouse Line | N | Age | Dox | Antibody | Injection sites | Time between injection and sacrifice |
|---|---|---|---|---|---|---|
| Line 107 | 4 | 6 | + | 5 μg 7B6 | 2 | 7 days |
| Line 107 | 4 | 6 | + | 5 μg IB3 | 2 | 7 days |
| Line 107 | 4 | 6 | + | 5 μg 6E10 | 2 | 7 days |
| Line 85 | 6 | 15 | + | 5 μg 6E10 | 2 | 7 days |
| Line 85 | 5 | 12 | − | 2 μg 6E10 | 1 | 3 days |
| Line 85 | 3 | 12 | − | 2 μg bio-6E10 | 1 | 24 h |
| Line 85 | 3 | 12 | − | 2 μg bio-6E10 | 1 | 3 days |
Line 107 or Line 85 mice received intracerebral injections of Aβ antibodies in the presence or absence of doxycycline chow (Dox) which suppresses amyloid precursor protein expression in Line 107 mice, and were sacrificed 3 or 7 days after injection. Age is given in months. Bio-6E10 refers to the biotinylated form of the 6E10 antibody.